SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-23-003438
Filing Date
2023-02-21
Accepted
2023-02-21 16:09:51
Documents
103
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K apls-20221231.htm   iXBRL 10-K 5289182
2 EX-10.33 apls-ex10_33.htm EX-10 55841
3 EX-21.1 apls-ex21_1.htm EX-21 26949
4 EX-23.1 apls-ex23_1.htm EX-23 3410
5 EX-31.1 apls-ex31_1.htm EX-31 21002
6 EX-31.2 apls-ex31_2.htm EX-31 21014
7 EX-32.1 apls-ex32_1.htm EX-32 12143
8 EX-32.2 apls-ex32_2.htm EX-32 11876
9 GRAPHIC img137255988_0.jpg GRAPHIC 26034
10 GRAPHIC img137255988_1.jpg GRAPHIC 107719
11 GRAPHIC img137255988_2.jpg GRAPHIC 259879
  Complete submission text file 0000950170-23-003438.txt   18680054

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT apls-20221231.xsd EX-101.SCH 106291
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT apls-20221231_def.xml EX-101.DEF 355634
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT apls-20221231_cal.xml EX-101.CAL 102627
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT apls-20221231_pre.xml EX-101.PRE 604037
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT apls-20221231_lab.xml EX-101.LAB 797889
97 EXTRACTED XBRL INSTANCE DOCUMENT apls-20221231_htm.xml XML 3423594
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38276 | Film No.: 23648182
SIC: 2834 Pharmaceutical Preparations